Change of Urinary Metabolic Profile Secondary to a Congenital Urine Flow Impairment (UFI) by Nuclear Magnetic Resonance (NMR) and Metabolomics Analysis
N/A
For the new-born, diagnosis and prognosis of congenital urine flow impairme...
Status
Unknown
Location
Hospices Civils de LYon - Hôpital Femme Mère Enfant
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2
This phase II trial studies how well cabozantinib works in combination with...
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
PHASE3
This phase III trial compares the usual treatment (treatment with ipilimuma...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute